Methods and compositions for microencapsulation of adjuvants

Details Methods and compositions for microencapsulation of adjuvants Methods and compositions for microencapsulation of adjuvants

1995-06-02

1997-07-01

Levy, Neil S.

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Particulate form

424493, 424499, 4242791, A61K 950

Patent

active

056436050

ABSTRACT:
Methods and compositions are provided for the encapsulation of adjuvants in PLGA microspheres for use as vaccines. Mixtures of microspheres are provided which release adjuvant at desired intervals to provide boosts with adjuvant.

REFERENCES:
patent: 4293539 (1981-10-01), Ludwig et al.
patent: 4524067 (1985-06-01), Arichi et al.
patent: 4652441 (1987-03-01), Okada et al.
patent: 4719246 (1988-01-01), Murdoch et al.
patent: 4728721 (1988-03-01), Yamamoto et al.
patent: 4767628 (1988-08-01), Hutchinson et al.
patent: 4849228 (1989-07-01), Yamamoto et al.
patent: 4897268 (1990-01-01), Tice et al.
patent: 4902515 (1990-02-01), Loomis et al.
patent: 4917893 (1990-04-01), Okada et al.
patent: 4919929 (1990-04-01), Beck et al.
patent: 4954298 (1990-09-01), Yamamoto et al.
patent: 4962091 (1990-10-01), Eppstein et al.
patent: 4990336 (1991-02-01), Silvestri et al.
patent: 5008116 (1991-04-01), Cahn
patent: 5015476 (1991-05-01), Cochrum et al.
patent: 5057540 (1991-10-01), Kensil et al.
patent: 5075109 (1991-12-01), Tice et al.
patent: 5126147 (1992-06-01), Silvestri et al.
patent: 5198533 (1993-03-01), Schally et al.
patent: 5242686 (1993-09-01), Chu et al.
O'Hagan et al. Biodegradable Microparticles--Immunology 73(2):239-242 (1991).
Tabata et al Activation of Macrophage--J. of Controlled Release 6: 189-204 (1987).
Alonso et al Determinants of Release--Pharm. Res. 10(7), 1993 pp. 945-953.
Jeffory et al., "The Preparation and Characterization of Poly(lactide-co-glycolide) Microparticles. II." Pharm. Res. 1:362-368 (1993).
Alonso et al., "Determinants of Release Rate of Tetanus Vaccine from Polyester Microspheres" Pharm. Res. 10 (7):945-953 (1993).
Arthur et al., "Challenge of chimpanzees (Pan troglodytes) immunized with human immunodeficiency virus envelope glycoprotein gp120" Journal of Virology 63(12):5046-5053 (1989).
Berman et al., "Human immunodeficiency virus type 1 challenge of chimpanzees immunized with recombinant envelope glycoprotein gp120" Proc. Natl. Acad. Sci. USA 85(14):5200-5204 (Jul. 1988).
Chang et al., "Biodegradable Semipermeable Microcapsules Containing Enzymes, Hormone, Vaccines, and Other Biologicals" J. Bioengineering 1:25-32 (1976).
Cohen, J., "Jitters Jeopardize AIDS Vaccine Trials" Science 262:980-981 (1993).
Cowsar et al., "Poly(lactide-co-glycolide) Microcapsules for Controlled Release of Steroids" Methods in Enzymology 112 (Drug and Enzyme Targ):101-116 (1985).
Eldridge et al., "Biodegradable and Biocompatible Poly(DL-Lactide-Co-Glycolide) Micropheres as an Adjuvant for Staphylococcal Enterotoxin B Toxoid Which Enhances the Level of Toxin-Neutralizing Antibodies" Infection and Immunity 59(9):2978-2986 (1991).
Eldridge et al., "Biodegradable Micropheres As a Vaccine Delivery System" Molecular Immuno. 28(3):287-294 (1991).
Eldridge et al., "Biodegradable Poly(DL-lactide-coglycolide) Microshperes" Res. Immunol. 143(5):557-563 (1992).
Esparza et al., "Parameters Affecting the Immunogenicity of Microencapsulated Tetanus Toxoid" Vaccine 10(10):714-720 (1992).
Glaser, V., "Solving the HIV Vaccine Puzzle: Questions Still Outnumber the Answers" Genetic Engineering News pp. 15-30 (Nov. 1, 1993).
Hu et al., "Effect of immunization with a vaccinia-HIV env recombinant on HIV infection of chimpanzees" Nature 328(6132):721-723 (Aug. 1987).
Kensil et al., "Development of a genetically engineered vaccine againsts feline leukemia virus infection" J. Amer. Veterinary Med. Assoc. 199(10):1423-1427 (1991).
Kohn et al., "Single-step Immunization Using a Controlled Release, Biodegradable Polymer with Sustained Adjuvant Activity" J. Immun. Methods 95:31-38 (1986).
Newman et al., "Immunogenicity and Toxicity Testing of an Experimental HIV-1 Vaccine in Nonhuman Primates" Aids Res. and Human. Retroviruses 8(8):1413-1418 (1992).
Nunberg et al., "Adjuvant Formulations to Increase the Virus-neutralizing Antibody Response to HIV-1 rgp120 Subunit Vaccine" Vaccines (Annu. Meet.), Norrby et al., 11th edition, N.Y.:Cold Spring Harbor Lab vol. 94:23-27 (Mod. Approaches New 1994).
O'Hagan et al., "Biodegradable Microparticles as Controlled Release Antigen Delivery System" Immunology 73(2):239-242 (1991).
Payne et al., "Water-Soluble Phosphazene Polymers for Parenteral and Mucosal Vaccine Delivery" Vaccine Design; The Subunit and Adjuvant Approach, Powell et al., New York, NY:Plenum Press vol. 6:473-493 (1995).
Putney, S., "How Antibodies Block HIV Infection: Paths to and AIDS Vaccine" TIBS 17:191-196 (1992).
Sanders et al., "Controlled Release of a Luteinizing Hormone-Releasing Hormone Analogue from Poly (d,1-lactide-co-glycolide) Microspheres" J. of Pharmaceutical Sciences 73(9):1294-1297 (1984).
Singh et al., "Controlled Delivery of Diphtheria Toxoid Using Biodegradable Poly(D,L-Lactide) Microcapsules" Pharmaceutical Research 8(7):958-961 (1991).
Tabata et al., "Activation of Macrophage In Vitro to Acquire Antitumor Activity by a Muramyl Dipeptide Derivative Encapsulated in Microspheres Composed of Lactide Copolymer" Journal of Controlled Release 6:189-204 (1987).
Van Preis, "A Single-step Immunization by Sustained Antigen Release" J. Immun. Methods 28:193-197 (1979).
Wang et al., "Influence of formulation methods on the in vitro controlled release of protein from poly(ester) micropheres" J. of Controlled Release 17:23-32 (1991).
White et al., "A purified Saponin Acts as an Adjuvant for a T-independent Antigen" Immunobiology of Proteins and Peptides VI, M.Z. Atassi, New York:Plenum Press pp. 207-210 (1991).
Wu et al., "Saponin Adjuvant Enhancement of Antigen-Specific Immune Responses To An Experimental HIV-1 Vaccine" J. of Immuno. 148(5):1519-1525 (1992).

Affiliated with

Also associated with

Rating

Methods and compositions for microencapsulation of adjuvants does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods and compositions for microencapsulation of adjuvants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for microencapsulation of adjuvants will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-594988